SCHEMBL7548979

SCHEMBL7548979

CCCCc1cc(C(=O)Nc2cccc(SCc3cncc4ccccc34)c2)ccc1O

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 13/20 0.41
MAPT P10636 3/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
HTR1A P08908 1/20 0.40
CYP2D6 P10635 1/20 0.40
ALOX15 P16050 1/20 0.40
HTR1D P28221 1/20 0.40
HTR1B P28222 1/20 0.40
CYP2C19 P33261 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MMP1 P03956 1/20 0.38
MMP9 P14780 1/20 0.38
HTT P42858 1/20 0.38
CXCR2 P25025 1/20 0.37
TOP1 P11387 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6846730 0.84 MAPT (0.39) MAPTCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL7490334 0.83 TRPV1 (0.52) TRPV1MAPTALDH1A1CYP1A2CYP3A4
SCHEMBL7541960 0.71 MEN1 (0.39) MAPTALDH1A1CYP1A2CYP3A4HTR1A
SCHEMBL7495398 0.70 MAPK1 (0.53) TRPV1ALDH1A1
SCHEMBL6841295 0.69 ADRB2 (0.47) MAPTALDH1A1MMP1MMP9HTT
SCHEMBL6846506 0.68 THRB (0.49)
SCHEMBL6846695 0.67 SIRT2 (0.45) MAPT
SCHEMBL6114713 0.66 TLR8 (0.45) TRPV1MAPTALDH1A1
SCHEMBL6844711 0.66 NR1H4 (0.53) TRPV1MAPTALDH1A1HTT
SCHEMBL6841307 0.64 MMP9 (0.44) ALDH1A1MMP1MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1252146-A1 AMIDE COMPOUNDS FOR INHIBITING PROTEIN KINASES AGOURON PHARMACEUTICALS, INC. (US) 2002-10-30 EP disclosed
WO-2001053274-A1 AMIDE COMPOUNDS FOR INHIBITING PROTEIN KINASES AGOURON PHARMACEUTICALS, INC. (US) 2001-07-26 WO disclosed